ResearcherHarbin Medical UniversityActive in the last 2 years
Gang Tan
Matched on ORCID iD 0000-0001-8096-4798; OpenAlex author ID A5008194834. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 4
2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: 1 paper
Papers 3
- The functional roles of deoxyelephantopin potential target circTNPO3 in regulating pancreatic cancer malignant phenotype and gemcitabine chemoresistance via mi… Last author DOI 10.3389/fphar.2025.1613560↗
- Deoxyelephantopin Suppresses Pancreatic Cancer Progression In Vitro and In Vivo by Targeting linc00511/miR-370-5p/p21 Promoter Axis. Last author DOI 10.1155/2022/3855462↗
- Disulfiram Synergizes with SRC Inhibitors to Suppress the Growth of Pancreatic Ductal Adenocarcinoma Cells in Vitro and in Vivo. Co-author DOI 10.1248/bpb.b21-00353↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Daolin Ji · 2 shared papers, 2022–2025 · strength 0.39
- Paper The functional roles of deoxyelephantopin potential target circTNPO3 in regulating pancreatic cancer malignant phenotyp… DOI 10.3389/fphar.2025.1613560↗
- Paper Deoxyelephantopin Suppresses Pancreatic Cancer Progression In Vitro and In Vivo by Targeting linc00511/miR-370-5p/p21 P… DOI 10.1155/2022/3855462↗
- Yi Xu · 2 shared papers, 2022–2025 · strength 0.39
- Paper The functional roles of deoxyelephantopin potential target circTNPO3 in regulating pancreatic cancer malignant phenotyp… DOI 10.3389/fphar.2025.1613560↗
- Paper Deoxyelephantopin Suppresses Pancreatic Cancer Progression In Vitro and In Vivo by Targeting linc00511/miR-370-5p/p21 P… DOI 10.1155/2022/3855462↗
- Xueying Sun · 1 shared paper, 2021 · strength 0.15
- Ziyi Li · 1 shared paper, 2021 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.